Technology Platform

Protein structure design and recombinant technology

1-1409291G144V0.jpg

   

 

We have used protein structure design technology to design pneumococcal protein antigens. In addition, we have developed novel recombinant strains to produce a new generation pertussis vaccine. We also developed a proprietary cell line to be used for viral vector production.